Spero Therapeutics (SPRO) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to $153000.0.
- Spero Therapeutics' Other Non-Current Assets changed 0.0% to $153000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $153000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $153000.0 for FY2024, which is 6482.76% down from last year.
- Per Spero Therapeutics' latest filing, its Other Non-Current Assets stood at $153000.0 for Q3 2025, which was down 0.0% from $153000.0 recorded in Q2 2025.
- Spero Therapeutics' Other Non-Current Assets' 5-year high stood at $5.9 million during Q1 2022, with a 5-year trough of $153000.0 in Q3 2024.
- Its 5-year average for Other Non-Current Assets is $3.1 million, with a median of $5.2 million in 2021.
- Per our database at Business Quant, Spero Therapeutics' Other Non-Current Assets surged by 1375.67% in 2022 and then plummeted by 9243.9% in 2024.
- Over the past 5 years, Spero Therapeutics' Other Non-Current Assets (Quarter) stood at $5.6 million in 2021, then grew by 1.7% to $5.7 million in 2022, then crashed by 92.42% to $435000.0 in 2023, then crashed by 64.83% to $153000.0 in 2024, then changed by 0.0% to $153000.0 in 2025.
- Its Other Non-Current Assets stands at $153000.0 for Q3 2025, versus $153000.0 for Q2 2025 and $153000.0 for Q1 2025.